Wenyi Lu
- Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 4
- Genetics top 5%
- Virus-based gene therapy research 12
- Mesenchymal stem cell research 5
- Hemoglobinopathies and Related Disorders 5
- Oncology top 10%
- CAR-T cell therapy research 21
-
- Immune Cell Function and Interaction 8
- Ophthalmology top 10%
-
- Viral Infectious Diseases and Gene Expression in Insects 7
- Cited by
- HematologyGeneticsOncology
In The Last Decade
Wenyi Lu
56 papers receiving 946 citations
Peers
Comparison fields: 5 of 80
- Hematology 307
- Genetics 207
- Oncology 372
- Immunology 175
- Ophthalmology 43
Countries citing papers authored by Wenyi Lu
This map shows the geographic impact of Wenyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Lu more than expected).
Fields of papers citing papers by Wenyi Lu
This network shows the impact of papers produced by Wenyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Lu. The network helps show where Wenyi Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenyi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 6 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 39 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 114 | |
| 16 | 2019 | 21 | |
| 17 | 2019 | 15 | |
| 18 | 2018 | 48 | |
| 19 | 2017 | 31 | |
| 20 | 2013 | 16 |
About Wenyi Lu
Wenyi Lu is a scholar working on Hematology, Genetics, Oncology, Immunology and Genetics, having authored 60 papers that have together received 958 indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (12 papers), Immune Cell Function and Interaction (8 papers), Acute Myeloid Leukemia Research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), Mesenchymal stem cell research (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Hematology (307 citations), Genetics (207 citations), Oncology (372 citations), Immunology (175 citations) and Ophthalmology (43 citations). Wenyi Lu has collaborated with scholars based in China and Canada. Frequent co-authors include Mingfeng Zhao, Xin Jin, Xiaoyuan He, Xia Xiao, Rui Sun, Juanxia Meng, Xiao Chai, Juan Mu, Lin Cheng and Cuicui Lyu. Their work appears in journals such as Frontiers in Immunology, Current Treatment Options in Oncology, Frontiers in Oncology, Blood and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.